Tsuchimoto Kim R (CIK 1333516) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-28). Recent activity: Buy MNPR (2,055 shares), Buy MNPR (2,035 shares), Sell MNPR (485 shares), Sell MNPR (615 shares), Sell MNPR (700 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Buy | 2,055 | $61,650 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Buy | 2,035 | $28,490 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 485 | $52,783 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 615 | $67,379 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 700 | $77,455 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 1,098 | $122,800 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 602 | $67,984 |
| 2026-08-28 | Monopar Therapeutics (MNPR) | Director | Sell | 590 | $67,166 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 485 | $52,783 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 615 | $67,379 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 700 | $77,455 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 1,098 | $122,800 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 602 | $67,984 |
| 2026-08-27 | Monopar Therapeutics (MNPR) | Director | Sell | 590 | $67,166 |
| 2025-07-16 | Monopar Therapeutics (MNPR) | Director | Buy | 8,904 | $89 |
| 2025-07-16 | Monopar Therapeutics (MNPR) | Director | Sell | 8,904 | $356,160 |
来源：SEC Form 4 申报文件 · 截至 2026-08-28